Spinal cord injury – Case Study- Stem cell therapy- Giostar – Video

Posted: September 15, 2014 at 1:40 am

Spinal cord injury - Case Study- Stem cell therapy- Giostar
a brief introduction to Giostar and its Stem cell therapy Dr.Divyang Patel (MD) a spine surgeon at Giostar- INDIA, briefs about a case of cervical spine injury, which is also examined by a...

By: Devang Parmar

More:
Spinal cord injury - Case Study- Stem cell therapy- Giostar - Video

Related Post

Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy ... - Nature.com - May 3rd, 2024
Replay wins IND clearance for PRAME T cell cancer therapy - Clinical Trials Arena - May 3rd, 2024
Dr Oluwole on the Use of CAR T-Cell Therapy in Autoimmune Disorders - OncLive - May 3rd, 2024
Cell Therapy is Now on The Table for Metastatic Melanoma - InventUM - University of Miami - May 3rd, 2024
Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th ... - PR Newswire - May 3rd, 2024
Bringing the science of cell therapy into autoimmune diseases - Bristol Myers Squibb - May 3rd, 2024
Quell Therapeutics Highlights Clinical Potential of QEL-001 and its Multi-Modular Treg Cell Therapy Platform at the ... - Yahoo Finance - May 3rd, 2024
The potential and promise for clinical application of adoptive T cell therapy in cancer - Journal of Translational Medicine - Journal of Translational... - May 3rd, 2024
NK Cell Therapy IGNK001 Receives FDA Orphan Drug Designation for AML - OncLive - May 3rd, 2024
Carbon Biosciences Announces Four Presentations at the American Society of Gene and Cell Therapy 27th Annual ... - PR Newswire - May 3rd, 2024
CAR T-Cell Therapy Broadens Second-Line Treatment in LBCL - Targeted Oncology - May 3rd, 2024
CAR T-Cell Therapy Market to Reach Valuation of USD 22.2 Billion By 2032: Astute Analytica - Yahoo Finance - May 3rd, 2024
Multiply Labs and Wilson Wolf Corporation Collaborate to Automate G-Rex Bioreactor for Cell Therapy Manufacturing - Business Wire - May 3rd, 2024
Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy - Business Wire - May 3rd, 2024
Ingenium Therapeutics Novel NK Cell Therapy Receives Orphan Drug Designation From FDA - PR Newswire - May 3rd, 2024
Cell and gene therapy companies trip at scalability hurdle - Pharmaceutical Technology - May 3rd, 2024
Panasonic and Shinobi team on cost-effective cell therapy tech - BioProcess Insider - May 3rd, 2024
The Future of Cell and Gene Therapy Purification - The Medicine Maker - May 3rd, 2024
BMS closes Redwood City cell therapy research site - Fierce Biotech - May 3rd, 2024
FDA drafts two guidances on safety testing for cell and gene therapy products - Regulatory Focus - May 3rd, 2024
Afamitresgene autoleucel as an effective T-cell therapy for synovial sarcoma and liposarcoma - Physician's Weekly - May 3rd, 2024
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual ... - GlobeNewswire - May 3rd, 2024
What Lies Ahead? Shaping the Future of Cell and Gene Therapy - Genetic Engineering & Biotechnology News - May 3rd, 2024
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting 2024 - GlobeNewswire - May 3rd, 2024
Somite Therapeutics to Present at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT) - PR Newswire - May 3rd, 2024
Cell Therapy Basics - February 21st, 2024
FDA Approves Amtagvi, First Cell Therapy for Skin Cancer - BioPharm International - February 21st, 2024
Cellenkos Approved to Proceed with CK0803 Neurotrophic T regulatory Cell therapy to Treat Second Cohort in ALS Trial - PR Newswire - February 21st, 2024
Astellas and Kelonia enter CAR-T cell therapy collaboration worth over $800m - PMLiVE - February 21st, 2024
Bridging Therapy With CAR T-Cell Therapy in LBCL - OncLive - February 21st, 2024
FDA approves first cell therapy to treat aggressive forms of melanoma - NPR - February 21st, 2024
Iovance, with approval of 'TIL' cell therapy, readies for complex launch - Yahoo Finance - February 21st, 2024
Cancer treatment: FDA approves type of cell therapy for patients with late-stage melanoma - FOX 26 Houston - February 21st, 2024
Pharmalittle: We're reading about weight loss drugs, a cell therapy for melanoma, and more - STAT - February 21st, 2024
On heels of cancer cell therapy win, Peninsula biotech looks to raise $211M - San Francisco Business Times - The Business Journals - February 21st, 2024
FDA approves cell therapy to treat melanoma - FOX 26 Houston - February 21st, 2024
Toddler Beats Childhood Leukemia After Car T-Cell Therapy - City of Hope - February 21st, 2024
FDA Approves First One-time Cell Therapy for a Solid Tumor - BioSpace - February 21st, 2024
Iovance wins FDA approval for cell therapy - BioProcess Insider - BioProcess Insider - February 21st, 2024
FDA Approves Iovance Cancer Treatment, the First Cell Therapy for a Solid Tumor - MedCity News - February 21st, 2024
Promising target for CAR T-cell therapy leads to potent antitumor responses against cutaneous and rare melanomas - Medical Xpress - February 21st, 2024
Reinforcing Cell Therapy with Microfluidic Cell Sorting - RegMedNet - February 21st, 2024
Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells - News-Medical.Net - February 21st, 2024
Understanding CAR T-Cell Therapy: Balancing the Risks and Benefits - Medriva - February 21st, 2024
Keeping Track: Iovance's Amtaqvi Approval Brings T Cell Therapy To Solid Tumors - Pink Sheet - February 21st, 2024
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be ... - Yahoo Finance - February 21st, 2024
What is CAR-T cell therapy, used for cancer treatment? Experts explain - India Today - India Today - February 21st, 2024
UPDATE: 2seventy splits once more, sending cell therapy pipeline to Regeneron in 'dramatic' change - FierceBiotech - January 31st, 2024
Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction - News-Medical.Net - January 31st, 2024
BioCardia Pivots to Biomarker Strategy to Prove Heart Failure Cell Therapy Benefits - precisionmedicineonline.com - January 31st, 2024
Sequencing With CAR T-Cell Therapy for LBCL - OncLive - January 31st, 2024
Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy ... - pnas.org - January 31st, 2024
Regeneron to acquire 2seventy's cell therapy pipeline - Yahoo Finance - January 31st, 2024
Trial of cell-based therapy CK08031 finishes dosing 1st patients - ALS News Today - January 31st, 2024
Exploring Gene and Cell Therapy Integration in Pharmacies - PharmaNewsIntel - January 31st, 2024
HBS Alumna Fighting Cancer with a Novel Cell Therapy - MBA - hbs.edu - January 31st, 2024
YUHS partners with KURE.AI Therapeutics for cell therapy development - KBR - January 31st, 2024
Global CAR-T Cell Therapy Market Report 2024-2034: Accelerated Growth Fueled by Intensive R&D, Growing Medical ... - Yahoo Finance - January 31st, 2024
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy ... - PR Newswire - January 31st, 2024
A new chapter in cell therapy: engineered B cells reach the clinic for the first time - Labiotech.eu - January 31st, 2024
Harnessing the Dark Genome: New Approach Greatly Improves Cancer T-Cell Therapy - SciTechDaily - January 31st, 2024
Cell therapies | Harvard Stem Cell Institute (HSCI) - November 16th, 2023
Oncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological... - April 15th, 2023
Basal Cell Carcinoma Treatment - The Skin Cancer Foundation - January 4th, 2023
Adoptive Cell Therapy - Cancer Research Institute (CRI) - December 27th, 2022
National Medical Commission prohibits use of stem cell therapy to treat patients with autism - Hindustan Times - December 18th, 2022
Tumor buster - where will the CAR-T cell therapy missile go? - December 18th, 2022
Gilead lands new cell therapy for Kite in $225M Arcellx deal, providing global scale for future J&J-Legend showdown - FierceBiotech - December 10th, 2022
Non-Small Cell Lung Cancer Treatment (PDQ)Patient Version - November 24th, 2022
CAR-T Cell Therapy Program - Frequently asked questions - November 24th, 2022
EdiGene Announces Completion of Last Patient Dosing in Phase I Clinical Trial of ET-01, its Investigational Gene-editing Hematopoietic Stem Cell... - November 24th, 2022
Radiation Therapy for Non-Small Cell Lung Cancer - November 6th, 2022
AvenCell to Present New Data from Lead Universal CAR T Cell Therapy Program at 64th American Society of Hematology Annual Meeting and Exposition -... - November 6th, 2022
Instil Bio's stock falls 35% after disclosing the cell therapy company paused enrollment in clinical trials - MarketWatch - November 6th, 2022
Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem, a Novel Cell Therapy for the... - November 6th, 2022
Photodynamic Therapy to Treat Cancer - NCI - October 29th, 2022
Researchers at University Hospitals create a breakthrough in CAR-T cell therapy for cancer patients - News 5 Cleveland WEWS - October 29th, 2022
Mustang Bio Announces Phase 1/2 Clinical Trial Data of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy, to be Presented at 11th... - October 29th, 2022
Gilead, working to improve cancer cell therapy, partners with California startup - BioPharma Dive - October 21st, 2022
Allogene starts first pivotal trials of an 'off-the-shelf' cell therapy for cancer - BioPharma Dive - October 13th, 2022